3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On October 7, 2026, NextNRG completed its reincorporation from Delaware to Nevada under a plan approved by stockholders on December 29, 2025, and filed new Nevada charter documents and certificates of designation for its Series A, B and C convertible preferred stock. The company said the move did not change its business, management, assets, liabilities or net worth, and its common stock continues to trade on Nasdaq under NXXT. Shareholders should note that stockholder rights are now governed by Nevada law and the new Nevada bylaws.
Reincorporation effective October 7, 2026; each common share and preferred share converted one-for-one into the Nevada corporation's equivalent
Amended and Restated Voting Agreement dated October 7, 2026, effective September 30, 2026, terminates on the later of required approvals (other than the Split Authorization) or December 31, 2028
Series A preferred carries a $10.00 stated value and a 10% annual dividend paid in common stock; holders are capped at 9.99% beneficial ownership
Oil-Dri Corporation of America amended its BMO credit agreement on October 7, 2026, raising its revolving line of credit from $75 million to $100 million and extending the termination date to October 7, 2031. The company also amended its Prudential note purchase agreement, raising the shelf note capacity from $75 million to $150 million, and both amendments add restrictions on dividends, distributions and share repurchases, which matter to shareholders.
BMO revolving line of credit increased from up to $75 million to up to $100 million, with the termination date extended to October 7, 2031.
Accordion provision allows an additional increase of up to the greater of $125 million or 100% of Consolidated EBITDA, subject to conditions.
Prudential shelf note capacity increased from $75 million to $150 million, with the issuance period extended to October 7, 2029.
New restricted payments covenant limits dividends, distributions and share repurchases unless the company is not in default and other specified conditions are met.
General Dynamics' board elected Danny Deep, the company's current president, as chief executive effective January 1, 2027. Chairman and CEO Phebe N. Novakovic, who has been CEO since 2013, will become executive chairman at that time, so shareholders face a planned leadership transition rather than an immediate change at the top.
Danny Deep, 56, has served as President since December 2025 and joined the board on August 5, 2026
Deep succeeds Phebe N. Novakovic, who has been CEO since 2013 and will become executive chairman
The CEO change takes effect January 1, 2027; the announcement was made October 7, 2026
Deep has been with the company for 25 years; the company reported $52.6 billion in revenue for 2025
PRA Group closed a $400 million private offering of 8.500% senior unsecured notes maturing October 15, 2033, dated October 2, 2026. The company plans to use the proceeds and cash on hand to repay about $400.0 million of borrowings under its North American revolving credit facility, which can be re-borrowed under customary conditions.
$400 million aggregate principal of 8.500% Senior Notes due October 15, 2033, issued October 2, 2026
Interest payable semiannually on April 15 and October 15, starting April 15, 2027
Proceeds and available cash to repay about $400.0 million of North American revolver borrowings; commitment amount unchanged
Notes guaranteed by domestic restricted subsidiaries that guarantee the North American Credit Agreement; Regions Bank is trustee
At its October 1, 2026 annual meeting, shareholders approved a trust amendment and charter amendment that let DT Cloud Star Acquisition Corporation extend its deadline to complete a business combination from October 26, 2026 to October 26, 2027. Each one-month extension requires a deposit of $0.033 per remaining public share into the trust account. In connection with the vote, 787,135 outstanding shares were tendered for redemption.
Annual meeting held October 1, 2026; 2,766,246 shares, about 75.72% of outstanding ordinary shares, were represented, and a quorum was present.
Trust amendment allows up to twelve one-month extensions, from October 26, 2026 to October 26, 2027, at $0.033 per remaining public share per extension.
787,135 outstanding shares were tendered for redemption in connection with the shareholder vote.
PepsiCo reported third-quarter 2026 net revenue of $25.3 billion, up 5.6%, and EPS of $2.23, up 17%, while core EPS rose 2% to $2.34. The company lowered its fiscal 2026 core EPS growth guidance to 2.5% to 3.5%, from a prior low end of 5% to 7%, and cut core constant currency EPS growth guidance to 1% to 2%. For shareholders, strong sales and reported profit gains are offset by a weaker profit outlook for the full year.
Q3 2026 net revenue was $25.3 billion, up 5.6%, with organic revenue up 3.1%
Q3 2026 EPS was $2.23, up 17%; core EPS was $2.34, up 2%
Fiscal 2026 core EPS growth guidance is now 2.5% to 3.5%, versus a prior low end of 5% to 7%
Fiscal 2026 net revenue growth guidance was raised to approximately 6%, from 4% to 6%
Scienture Holdings, Inc. (Nasdaq: SCNX) effected a 1-for-25 reverse stock split at 12:01 a.m. Eastern Time on October 5, 2026, after its board approved the split on September 17, 2026. The company said the split is intended to help it regain compliance with Nasdaq's $1.00 minimum bid price rule. Shareholders' proportional ownership is stated to remain virtually unchanged, but the number of shares outstanding falls sharply.
Split ratio: 1-for-25, so every 25 shares became one share; the company expects about 1,642,565 shares outstanding after the split, down from 41,064,146 as of September 30, 2026.
Reason given: to regain compliance with Nasdaq's continued listing rule requiring a minimum bid price of at least $1.00 per share.
Fractional shares were not issued; holders entitled to fractions receive a cash payment in lieu.
Trading symbol remains SCNX under a new CUSIP, 80880X203 (the 8-K states 8088X203 in one place).
On October 1, 2026, Vylor completed exchange offers and consent solicitations for senior notes issued by EIDP, Inc., issuing $1,438,218,000 of new Vylor senior unsecured notes in exchange for the EIDP notes accepted. The filing adds this amount to Vylor's debt obligations, with interest rates of 2.300%, 5.125% and 4.800% and maturities from 2030 to 2033, and it does not report earnings or cash flow effects.
Vylor issued $1,438,218,000 aggregate principal of senior notes on October 1, 2026, in exchange for accepted EIDP notes.
2030 Notes: $434,741,000 at 2.300%, maturing July 15, 2030; 2032 Notes: $475,977,000 at 5.125%, maturing May 15, 2032; 2033 Notes: $527,500,000 at 4.800%, maturing May 15, 2033.
The Vylor notes are senior unsecured obligations, not guaranteed by others; Vylor agreed to complete an exchange offer or shelf registration within 366 days of the settlement date.
Vylor Inc. became an independent public company on October 1, 2026, when Corteva's Pioneer Hi-Bred unit was contributed to it in the Separation and Corteva shares were distributed. Vylor issued 667,302,930 shares to EIDP, a Corteva subsidiary, and paid EIDP an aggregate cash distribution of about $761 million, subject to adjustments. The filing also reconstitutes the board and management team and changes the independent auditor, which shareholders will need to follow in future filings.
On October 1, 2026, Vylor issued 667,302,930 common shares to EIDP, Inc., a wholly owned subsidiary of Corteva, in exchange for Pioneer Hi-Bred and a cash distribution of about $761 million.
Pioneer Hi-Bred borrowed $1,578 million under a five-year revolving credit facility and $1,500 million under a 364-day revolving credit facility, using the proceeds to repay $3,078 million under a bilateral loan.
Seven directors were appointed effective at the Effective Time, and Charles V. Magro was named Chief Executive Officer; Judd M. O'Connor ceased serving as President.
PricewaterhouseCoopers LLP was appointed as independent registered public accounting firm to audit the fiscal year ending December 31, 2026.
Corteva disclosed board and officer changes tied to its Separation, effective at the Effective Time. Luther (Luke) Kissam became Chief Executive Officer and Jeff Rudolph became Chief Financial Officer, and four directors resigned from the board. Shareholders will be watching how the new leadership team and reshaped board guide the company after the Separation.
Luther (Luke) Kissam was appointed Chief Executive Officer, and Jeff Rudolph was appointed Chief Financial Officer, effective as of the Effective Time.
Charles V. Magro, Kerry J. Preete, Marcos M. Lutz and Karen H. Grimes resigned from the Board, with Magro also leaving his officer roles.
Kissam was appointed as a director, and Brook Cunningham and Ralph Ford were named Chief Commercial Officer and Chief Integrated Operations Officer.
On October 1, 2026, Vylor Inc. completed private exchange offers for three series of EIDP, Inc. senior notes, swapping eligible holders' notes for new Vylor notes, along with consent solicitations to adopt amendments to the EIDP note indentures. Tendered EIDP notes that were accepted have been retired and canceled, and the remaining principal amounts stay outstanding. Shareholders should note that the amended indenture terms took effect on October 1, 2026, and that the exchanged notes were not registered under US securities laws.
2.300% Senior Notes due 2030: $434,839,000 accepted; $65,161,000 outstanding after settlement
5.125% Senior Notes due 2032: $476,214,000 accepted; $23,786,000 outstanding after settlement
4.800% Senior Notes due 2033: $527,584,000 accepted; $72,416,000 outstanding after settlement
Requisite consents received by the August 19, 2026 early tender deadline; Fourth Supplemental Indenture dated August 20, 2026
On October 1, 2026, Host Digital's board granted 342,864 shares of Class A common stock as restricted stock to certain employees, including CFO John Ollet, who received 74,286 shares. The company also agreed to register for resale up to 342,864 shares held by certain holders, which could add shares available for sale in the market, and the filing states the grants were made under the May 27, 2026 merger agreement with Healthy Choice Wellness II Corp. and Host Digital Infrastructure LLC.
October 1, 2026: board granted 342,864 restricted shares of Class A common stock to employees, including CFO John Ollet (74,286 shares)
Restricted shares vest in full on November 30, 2026, unless Ollet resigns voluntarily or is terminated for cause
Registration rights agreement covers resale of up to 342,864 shares; shelf registration due within 30 calendar days after September 17, 2026
Grants made pursuant to the May 27, 2026 merger agreement with Healthy Choice Wellness II Corp. and Host Digital Infrastructure LLC
Healthcare Services Group agreed on October 6, 2026 to buy NexDine, LLC and Xendella, LLC (together NEXDINE Hospitality) for an aggregate price of approximately $93.5 million, plus contingent payments tied to performance conditions. The company paid the cash due at closing from cash on hand, and its press release says the business is expected to contribute over $150 million in annual revenue. The deal expands the company's presence in senior living and hospitality services, but the filing does not disclose the acquired business's profit.
Purchase Agreement dated October 6, 2026 with Real Artisan Brands, LLC and other seller parties
Aggregate price of approximately $93.5 million, subject to customary adjustments, plus contingent consideration
Funded with cash on hand; press release says NEXDINE is expected to contribute over $150 million in annual revenue
NEXDINE will remain a wholly-owned subsidiary headquartered in Mansfield, Massachusetts, led by Founder and CEO David Lanci
BCB Bancorp appointed Steven E. Gallotta and Denny Kim to its board and Patricia M. Schaubeck as Executive Vice President, Chief Legal Officer and Corporate Secretary, effective October 7, 2026, as part of a reorganization of its legal department and C-suite. The filing discloses no financial results, and the company does not state any financial effect of the changes.
Steven E. Gallotta, a former KPMG audit partner, joins the board and will serve on the Audit Committee.
Denny Kim, founder of Whale Point Capital, joins the board and will serve on the Nominating and Corporate Governance Committee.
Patricia M. Schaubeck joins as Executive Vice President, Chief Legal Officer and Corporate Secretary, with an annual base salary of $444,600.
Both new directors serve until the 2027 annual meeting of shareholders, and the board determined both are independent.
W&T Offshore signed a second amendment to its credit agreement on October 1, 2026, converting its revolving credit facility into a reserve-based facility with an initial $50.0 million borrowing base and elected commitments. The company says the amendment removes the cash sweep, quarterly clean-down and asset coverage covenant, and raises the annual restricted payments cap from $10.0 million to $15.0 million, with pricing and financial covenants unchanged.
Facility matures on the earlier of July 28, 2028 and six months before the Senior Second Lien Notes mature; aggregate maximum credit amount is $100.0 million
Initial borrowing base and elected commitment are $50.0 million; borrowing base redetermined semi-annually starting November 1, 2026
Annual restricted payments cap raised from $10.0 million to $15.0 million; net leverage covenant remains at most 2.50 to 1.00
Macquarie Bank exited the facility; Canadian Imperial Bank of Commerce joined with a $10.0 million commitment
Clearway Energy subsidiary Honeycomb 2 Purchaser LLC agreed on October 1, 2026 to acquire interests in three battery energy storage projects in Utah from an affiliate of Clearway Energy Group for a base price of about $119 million in cash, subject to adjustments. The projects, about 210 megawatts in total, are still in development, and closing is expected in the fourth quarter of 2027, subject to conditions.
Base purchase price of approximately $119 million in cash, subject to adjustments tied to a financial model with minimum economic thresholds.
Three battery storage projects (Escalante BESS II, Escalante BESS III, Granite Mountain BESS West) totaling about 210 megawatts in Beaver and Iron counties, Utah.
Closing expected during the fourth quarter of 2027, subject to customary conditions and third-party actions.
Filing does not include financial results or earnings impact of the transaction.
Applied Digital reported fiscal first quarter 2027 results for the period ended August 31, 2026. Revenue rose 322% to $341.9 million, but the net loss attributable to common stockholders widened to $221.0 million, or $0.76 per share, from $18.5 million, or $0.07 per share, a year earlier. The company also reported non-GAAP adjusted net loss of $4.1 million, or $0.01 per diluted share, which excludes its majority-owned ChronoScale subsidiary.
Revenue was $341.9 million, up 322% from the prior year period; adjusted revenue, which excludes ChronoScale, was $300.4 million versus $64.2 million
Net loss attributable to common stockholders was $221.0 million ($0.76 per share), compared with $18.5 million ($0.07 per share) a year earlier
Adjusted EBITDA was $64.4 million versus $0.5 million a year earlier; interest expense rose to $77.4 million
Cash, cash equivalents and restricted cash were $3.7 billion and debt was $6.4 billion as of August 31, 2026
Stoneridge subsidiary Orlaco Products signed an employment agreement with Vivek Anand, who will become Vice President, Commercial Strategy & Global Sales on November 2, 2026, reporting to CEO Natalia Noblet and serving on the executive team. He will lead the global commercial organization, including sales, product marketing, and market analytics. The filing gives his pay terms but no financial results or guidance.
Employment agreement dated October 2, 2026; role starts November 2, 2026
Annual base salary of €330,000 (about $371,349) with a 50% target annual bonus
€50,000 sign-on bonus (about $56,265), repayable if he resigns or is terminated for cause before November 2, 2027
One-time special equity grant of €150,000 (about $168,795) in time-based shares, vesting one year after grant
On October 2, 2026, loanDepot.com, LLC and its subsidiary loanDepot Multi Asset NC, LLC entered into a Master Repurchase Agreement with Nomura Corporate Funding Americas, LLC, allowing the company to sell and later repurchase residential mortgage loans and certain real estate owned interests. The filing describes uncommitted financing of up to $125 million that expires September 30, 2027, and says the company must cure any margin deficit at the buyer's request, which could affect shareholders if a shortfall arises.
Agreement dated October 2, 2026, with Nomura Corporate Funding Americas, LLC as buyer
Aggregate uncommitted financing of up to $125 million
Expiration date September 30, 2027, unless extended or terminated earlier
Company must cure any margin deficit at the buyer's request; an event of default could terminate financing and accelerate repurchase obligations
TTEC Holdings entered into a Twelfth Amendment to its credit agreement with Wells Fargo as administrative agent, effective October 1, 2026. The amendment reduces revolving commitments by $15 million to $960 million, delays a scheduled margin increase, and removes a 1.50% extension fee, while the company paid a $2.4 million upfront fee to lenders.
Aggregate revolving commitments reduced by $15 million to $960 million; borrowings capped at $950 million.
Applicable margin stays at 3.250% (SOFR) and 2.250% (base rate) through November 15, 2026, instead of September 30, 2026.
Margin rises to 6.250% and 5.250% on November 16, 2026, unless a later amendment changes it.
Company paid lenders a $2.4 million upfront fee (0.25% of commitments); the 1.50% extension fee due October 1, 2026 was eliminated.
American Resources Corporation received a Nasdaq letter granting an additional exception through November 16, 2026 to file its delinquent quarterly reports for the periods ended March 31 and June 30, 2026. The company says it is working to file both reports before the earlier October 15, 2026 deadline, and that the Nasdaq letter has no immediate effect on the listing or trading of its Class A common stock under the symbol AREC.
Nasdaq granted an exception through November 16, 2026 to file the March and June 2026 Forms 10-Q, after an earlier October 15, 2026 deadline for the March report.
The June Form 10-Q became delinquent, which led the company to submit an updated compliance plan requesting more time.
The company is working toward filing both reports before October 15, 2026, and says the stock continues to trade on The Nasdaq Capital Market as AREC.
Universal Safety Products, Inc. (NYSE American: UUU) will change its name to DeFi Capital Markets, Inc. effective October 19, 2026, and its stock is expected to trade under the ticker DCM on that date. The company also changed its fiscal year end from March 31 to December 31, and it said it anticipates discontinuing its legacy safety products business as it builds tokenization, proprietary trading and digital asset market-making operations.
Name change to DeFi Capital Markets, Inc. and ticker change to DCM take effect October 19, 2026; CUSIP is unchanged and no action is required from existing stockholders.
Fiscal year end moves from March 31 to December 31; the next fiscal year end is December 31, 2026, with a transition report on Form 10-K covering April 1, 2026 to December 31, 2026.
The company anticipates discontinuing its legacy business of designing and marketing safety products as its tokenization and digital asset initiatives gain traction.
The filing gives no financial results, revenue or profit figures.
Nutanix director Craig Conway will not stand for re-election at the 2026 annual meeting, and he will serve until then. The company also signed a twelve-month advisory agreement with former President and Chief Commercial Officer Tarkan Maner, who stepped down earlier, under which he will be paid $37,500 per month. The filing describes these as leadership transitions and does not report any financial results.
Craig Conway notified the company on October 5, 2026 that he will not stand for re-election to the Board at the 2026 annual meeting.
Tarkan Maner entered a Transition Advisory Services Agreement on October 7, 2026, for a twelve-month term.
Maner's advisory fee is $37,500 per month, with no severance, new equity awards or accelerated vesting.
The agreement may be terminated for cause or by either party on 30 days' notice; the full text is expected in the 10-Q for the quarter ending October 31, 2026.
Richardson Electronics reported first-quarter fiscal 2027 results for the period ended August 29, 2026, with net sales up 18.9% and net income up 112.6% year over year. The company also declared a $0.06 per share quarterly dividend, and its backlog rose 36.9% to $184.4 million, which suggests continued demand growth for shareholders to watch in future filings.
Net sales were $64.9 million, up 18.9% from $54.6 million a year earlier, with all three business units growing.
Net income was $4.1 million, or $0.27 per diluted share, versus $1.9 million, or $0.13 per diluted share, a year earlier.
Gross margin was 34.6% versus 31.0%, with the company citing a 1.7-point benefit from an IEEPA tariff refund.
The board declared a $0.06 per share dividend, payable November 25, 2026, to holders of record as of November 6, 2026.
Wolfspeed announced a conditional commitment letter with the U.S. Department of War's Office of Strategic Capital for a senior secured delayed-draw term loan of up to $1.5 billion. Entry into the facility depends on due diligence, definitive agreements, government approvals and conditions such as raising at least $750 million of qualifying sources and issuing warrants for up to 7.5% of fully diluted equity.
Facility of up to $1.5 billion with a currently expected 30-year maturity and a 36-month draw period; initial tranche of $600 million would refinance first lien senior secured notes due 2030
Provisional risk premium of 1.25% to 1.75% over a comparable U.S. Treasury rate, subject to final agreements
Company must raise a Minimum Contribution of at least $750 million, including $50 million before the facility's effective date, and issue warrants to the DoW for 5% and 2.5% of outstanding equity
Filing states no assurance that definitive agreements will be signed or that financing will be provided
Rivian said the $1.0 billion, 10-year term loan tied to its Volkswagen joint venture was funded on October 7, 2026. The debt is non-recourse to Rivian, and the company says it intends to use the proceeds for general corporate purposes.
Loan B: $1.0 billion at a 6.03% fixed rate, borrowed by Rivian SPV and secured only by its 50% joint venture equity
Loan A: $1.0 billion at a 5.93% fixed rate, borrowed by the joint venture from Volkswagen Specter LLC
Both loans mature October 7, 2036; principal amortization of $100.0 million a year starts on the third anniversary
Rivian is not a guarantor; the sole recourse for a Loan B default is to the collateral
EQT Corporation set up a commercial paper program on October 7, 2026, allowing it to issue short-term unsecured notes with total outstanding face amount not to exceed $3.5 billion. As of the filing date, the company had not issued any notes under the program, and it plans to keep backstop capacity under its senior unsecured revolving credit facility at least equal to notes outstanding.
Program cap: $3.5 billion aggregate principal outstanding at any time, unless increased under dealer agreements
Maturities up to 397 days from issuance; proceeds for general corporate purposes, including capital expenditures and acquisitions
Senior unsecured revolving credit facility expected to serve as liquidity backstop; no notes issued as of the filing
lululemon appointed Maggie Gauger as President and Chief Product Officer and Joseph Godsey as Chief Operating Officer, both newly created roles effective October 26, 2026. Chief Brand & Product Activation Officer Nikki Neuburger and Chief Supply Chain Officer Ted Dagnese will leave the company on November 6, 2026, and CFO Meghan Frank takes on expanded responsibilities, including interim oversight of the global brand and technology functions.
Maggie Gauger: annual base salary of $1,000,000, bonus target of 150% of base salary, $1,900,000 sign-on bonus, and a one-time RSU grant valued at $2,800,000 vesting over two years
Joseph Godsey: annual base salary of $700,000, bonus target of 100% of base salary, $650,000 sign-on bonus, and a one-time RSU grant valued at $2,000,000 vesting over two years
Neuburger and Dagnese depart November 6, 2026; each departure is treated as a termination without cause under their employment agreements
Searches are underway for a Chief Brand Officer, Chief Communications Officer, Chief Technology Officer and Chief Strategy Officer
Armstrong World Industries said Senior Vice President of Sales and Marketing Jill A. Crager intends to retire effective December 31, 2026, after 28 years with the company. The company will begin identifying a successor, and Crager plans to stay engaged and help with the transition until she retires.
Jill A. Crager notified the company on October 5, 2026 of her intent to retire.
Retirement is effective December 31, 2026, after 28 years of service.
The company will start a search process for her successor.
Crager will remain involved in leading sales and marketing and assist with the transition until retirement.
Levi Strauss reported third-quarter 2026 net revenues of $1.6 billion, up 4% on a reported basis, and adjusted diluted EPS of $0.48 versus $0.34 a year earlier. The company raised its full-year 2026 adjusted diluted EPS guidance to $1.54 to $1.56 from $1.46 to $1.52 and plans a $100 million accelerated share repurchase. Tariff refunds boosted Q3 margins and profit, but management said direct-to-consumer sales fell short of internal expectations.
Q3 2026 adjusted diluted EPS was $0.48 versus $0.34 in Q3 2025; GAAP diluted EPS from continuing operations was $0.43 versus $0.31.
Tariff refunds contributed $0.16 of Q3 EPS, of which about $0.05 was redeployed to support the business.
DTC net revenues rose 2%, while U.S. DTC net revenues decreased 1%; management said DTC fell short of internal expectations.
Full-year 2026 adjusted diluted EPS guidance was raised to $1.54 to $1.56; a $100 million ASR is planned and a $0.16 dividend is payable November 4, 2026.
On October 7, 2026, Skyworks completed exchange offers for Qorvo senior notes due 2029 and 2031, issuing new Skyworks notes with matching coupon rates and maturity years in exchange. Skyworks issued $778,096,000 of new 2029 notes and $646,805,000 of new 2031 notes, so these become direct senior unsecured obligations of Skyworks. The filing does not state the effect of the exchange on Skyworks' total debt or interest costs.
Accepted and retired $779,384,000 of 4.375% 2029 Qorvo Notes and $647,096,000 of 3.375% 2031 Qorvo Notes; $70,616,000 and $52,904,000 remain outstanding.
Issued $778,096,000 of 4.375% New 2029 Skyworks Notes maturing October 15, 2029, and $646,805,000 of 3.375% New 2031 Skyworks Notes maturing April 1, 2031.
Exchange offers expired at 5:00 p.m. New York City time on October 5, 2026, and the notes are governed by an indenture dated August 10, 2026 with U.S. Bank Trust Company, National Association.
The new notes are senior unsecured obligations of Skyworks and are structurally subordinated to all obligations of its subsidiaries.
MicroVision reaffirmed its full-year 2026 revenue guidance of $10 million to $15 million and said it expects revenue to double in 2027, in an October 7, 2026 virtual business update. The company also said cost reductions and capital allocation changes are expected to produce a significant reduction in cash burn in 2027 compared with 2026, and it will provide more detail on its third quarter at its upcoming Q3 2026 earnings call.
2026 revenue guidance reaffirmed at $10 million to $15 million.
Revenue projected to double in 2027, driven by industrial, security and defense, and infrastructure markets.
Significant reduction in cash burn expected in 2027 compared with 2026; no specific figures given.
Additional third quarter 2026 results and outlook to be discussed on the upcoming Q3 2026 earnings call.
Riley Exploration Permian's subsidiary repaid all $130.0 million of its 10.50% Senior Unsecured Notes due 2028 on October 5, 2026, at 100% of principal plus accrued interest, with no prepayment premium. The prepayment was funded by a $130 million borrowing under the company's Credit Agreement, so total debt is substantially unchanged, though the credit facility now carries secured, floating-rate terms and a maturity of December 13, 2028.
Senior Notes of $130.0 million repaid at 100% of principal plus accrued interest on October 5, 2026, with no prepayment premium
Company expects a non-cash loss on extinguishment of debt from writing off unamortized discount and deferred financing costs; amount not stated
Funded by $130 million borrowing under the Credit Agreement with Truist Bank as administrative agent; facility balance $245 million, borrowing base $425 million, elected commitments $400 million
Credit Agreement borrowings are secured by substantially all company assets; SOFR loans priced at 2.75% to 3.75% above Term SOFR
Medicus Pharma Ltd. said it will consolidate its common shares on a 50-to-1 basis, effective October 12, 2026, with trading on a post-consolidation basis starting that day under the same ticker, MDCX. The company says the change is intended to raise the bid price of its shares and help it regain compliance with Nasdaq's minimum bid price requirement.
Every 50 common shares will be exchanged for one new common share, effective October 12, 2026.
Shareholders approved the consolidation, with a ratio of up to 50-to-1, at the June 3, 2026 annual meeting.
Fractional shares will be rounded down and cash paid in lieu; the new CUSIP is 58471K301 and ticker stays MDCX.
Resources Connection (RGP) reported a first-quarter fiscal 2027 net loss of $8.0 million, or $0.23 per diluted share, versus a $2.4 million loss, or $0.07 per share, a year earlier, as revenue fell 18.4% on a constant currency basis to $98.1 million. Revenue fell across both headline segments, and the company reported an adjusted EBITDA loss of $3.6 million, compared with positive adjusted EBITDA of $3.1 million a year earlier.
Revenue was $98.1 million versus $120.2 million; billable hours fell 13.2% and the average bill rate fell 5.8%.
Consulting revenue fell 25.8% to $32.4 million; On-Demand Talent revenue fell 13.2% to $38.6 million.
SG&A expenses declined to $43.1 million from $47.9 million, but were not enough to offset lower revenue.
Cash and cash equivalents were $61.2 million at August 29, 2026, down from $82.4 million at May 30, 2026, after $18.9 million of cash used in operations.
FatPipe entered two KeyBank business loan agreements: a $4.5 million secured term loan, of which about $4.47 million repaid its Fortis Bank SBA loan on October 1, 2026, and a $1.5 million secured revolving line of credit for working capital. The company expects an approximately 110 basis point reduction in its annual borrowing rate, but the loans carry quarterly financial covenants and default provisions that let KeyBank accelerate the debt.
Term loan of $4.5 million matures October 1, 2029, with 35 monthly principal payments of $75,000 beginning November 1, 2026.
Interest rate moves from Prime Rate plus 1.00% to Adjusted Daily SOFR plus 3.00%; the company expects an approximately 110 basis point reduction in its annual borrowing rate.
Revolving line of credit of $1.5 million matures September 30, 2027; origination fees are $22,500 for the term loan and $7,500 for the revolver.
Loans are guaranteed by subsidiary FatPipe Technologies, Inc. and secured by substantially all personal property assets, with covenants requiring Total Funded Debt to EBITDA no greater than 2.50 to 1.00 and Fixed Charge Coverage Ratio of at
Tessera Defense and Homeland Security filed an 8-K on October 7, 2026, disclosing new employment agreements with CEO Michael Oster and CFO David Rokach. Oster's package includes options on 1,000,000 shares at $1.15, 1,000,000 restricted stock units and 400,000 fully vested shares, plus performance grants tied to EBITDA per share for 2027 and 2028. Most equity awards require stockholder approval at an October 20, 2026 special meeting to raise the plan's share reserve from 685,000 to 6,000,000 shares.
Oster: monthly salary of NIS 55,000 (about $18,000) and an annual cash bonus of up to 50% of base salary
Oster equity: options on 1,000,000 shares at $1.15, 1,000,000 RSUs (25% vesting December 31, 2026) and 400,000 fully vested shares
Oster performance grants: up to 500,000 shares each for fiscal 2027 and 2028, starting when EBITDA per share exceeds $0.05 and $0.10
Rokach: monthly salary of NIS 35,000 (about $11,500) and 180,000 fully vested shares, subject to stockholder approval
T3 Defense Inc. said its board appointed Shlomo Zakai as Chief Financial Officer, effective October 5, 2026, serving at the board's discretion. He will be paid $13,000 per month plus VAT under a consulting agreement that either party can end on 30 days' notice.
Shlomo Zakai, 56, appointed CFO; appointment effective October 5, 2026 and announced October 7, 2026
Compensation is $13,000 per month plus VAT under a consulting agreement, filed as Exhibit 10.58
Zakai previously served as CFO of Duke Robotics Corp. (NASDAQ:DUKR) from May 19, 2020 to October 1, 2026
Helmerich & Payne said it expects direct margins for its North America, International and Offshore Solutions segments to be at or near the high end of previously issued guidance for the fourth quarter of fiscal 2026. The company also said all other financial guidance from its August 5, 2026 earnings release is unchanged, and it maintained its base dividend and its target of about 1x net debt to adjusted EBITDA by calendar year-end 2027. These figures are preliminary, unaudited and subject to financial closing procedures.
North America Solutions rig count expected near the high end of the fiscal Q4 2026 guidance range
International Solutions direct margins expected to be around $45 million for the quarter
International and Offshore Solutions rig counts expected near the midpoint of their guidance ranges
All other guidance from the August 5, 2026 earnings release is unchanged
Cadrenal Therapeutics said its Board of Directors has authorized a formal strategic process to evaluate opportunities to maximize the value of the company and its asset portfolio, including licensing, asset sales, partnerships, portfolio transactions, or business combinations. The company describes the review as preliminary, with no set deadline and no assurance it will lead to any transaction, and it does not plan to update shareholders until the Board approves a specific transaction or disclosure is otherwise required.
The Board authorized the strategic process, announced in a press release dated October 7, 2026.
Tungsten Advisors is engaged as the company's exclusive strategic financial adviser.
The review covers CAD-1005, tecarfarin, frunexian, and CAD-2000.
No deadline or definitive timetable has been set, and the company will not provide updates unless a specific transaction is approved or disclosure is required.
Pulse Biosciences said its NANOPULSE-AF pivotal study of the nPulse Cardiac Catheter System for atrial fibrillation reached its enrollment target of 164 evaluable patients across 15 clinical sites. The company said enrollment finished three months ahead of its original 9-month timeline, and primary safety and effectiveness endpoints will be assessed at 6 and 12 months after ablation, so the filing contains no financial results or guidance.
Study reached its target of 164 evaluable patients across 15 clinical sites
First patients were treated in April 2026
Enrollment finished three months ahead of the original 9-month timeline
Primary endpoints will be assessed at 6 and 12 months post-ablation
Coffee Holding Co., Inc. announced that its Board approved a share repurchase program allowing it to buy back up to $2.5 million of its common stock on the open market or in private transactions, subject to market conditions and other factors. The company intends to fund the program with available cash and future operating cash flow, and CEO Andrew Gordon said the company believes the stock price does not reflect its underlying fundamentals.
Authorized repurchases of up to $2.5 million in common stock, par value $0.001 per share
Funding from available cash and future cash flow from operations
Program may be discontinued or suspended at any time; part of repurchases may be made under a Rule 10b5-1 plan
Announced October 7, 2026 in a press release (Exhibit 99.1)
On October 5, 2026, BioNexus Gene Lab Corp. agreed to an exclusive Malaysian healthcare licence to Ruanyun Edai Technology's CogniAI document-intelligence platform, with closing still pending. The company will issue a total of 560,000 common shares, about 16.0% of its outstanding shares after issuance, with no cash payment, which shareholders would bear as dilution. The filing states that BioNexus has not been awarded any government contract and that closing depends on technology acceptance, due diligence and approvals.
Share consideration: 410,000 shares for a stated US$3.5 million licence fee, plus 150,000 shares for 500,000 RYET ordinary shares, totaling 560,000 shares, or about 16.0% of outstanding common shares after issuance.
Royalty: RYET receives 10% of defined technology receipts actually collected, with no minimum royalty or annual platform fee.
Closing: either non-defaulting party may terminate if closing has not occurred by March 31, 2027, unless extended.
Government work: BioNexus has not been awarded any government contract, and any public-sector work would depend on government procurement.
Nasdaq granted Onfolio an extension, set in an October 5, 2026 letter, to regain compliance with its $2.5 million minimum stockholders' equity requirement by November 23, 2026. The company also did not meet the alternative market value or net income standards, and the filing states there is no assurance it will regain or maintain compliance. If it does not, Nasdaq Staff will issue a written delisting notice that the company may appeal to a Nasdaq Hearings Panel.
Nasdaq notified the company on May 26, 2026 that it failed to meet the $2.5 million minimum stockholders' equity requirement under Listing Rule 5550(b)(1).
Nasdaq's letter dated October 5, 2026 extends the compliance deadline to November 23, 2026.
The company may be subject to delisting if it fails to evidence compliance when filing its periodic report for the year ending December 31, 2026.
The letter has no immediate effect on the listing or trading of the common stock on the Nasdaq Capital Market.
AIB Data Centers issued a shareholder letter from CEO Jerry Tang highlighting a 12-year agreement with Nebius for 50 MW of critical IT capacity at its CLT1 campus, plus a Texas acquisition that raised contracted utility power from 65 MW to about 120 MW. The company said it does not currently anticipate needing corporate-level common equity to fund CLT1, relying instead on customer prepayments and project-level debt or preferred equity.
Nebius agreement: 12-year initial term for 50 MW of critical IT capacity at CLT1, with two potential five-year renewals
Contracted utility power increased from 65 MW to approximately 120 MW after a Texas acquisition
Company does not currently anticipate requiring corporate-level common equity to fund CLT1 development
The filing contains no revenue, profit or financial figures for the period
Launch Two Acquisition Corp. (LPBB) has again postponed its extraordinary general meeting, now set for Thursday, October 8, 2026, at 1:00 p.m. Eastern Time. The vote concerns an amendment that would let the company extend its deadline to complete an initial business combination in monthly steps, up to six times, from October 9, 2026 to April 9, 2027, and shareholder redemption deadlines were also pushed back to October 7, 2026.
Meeting moved from October 6, then October 7, 2026 to Thursday, October 8, 2026 at 1:00 p.m. Eastern Time.
Proposed extension would move the business combination deadline from October 9, 2026 to April 9, 2027, in up to six monthly steps.
Redemption rights deadline extended to Wednesday, October 7, 2026 at 5:00 p.m. Eastern Time.
FuelCell Energy appointed Matthew Latino as Executive Vice President, Chief Financial Officer and Treasurer effective October 7, 2026, replacing Michael S. Bishop, who ends his CFO role effective October 6, 2026 and becomes Senior Advisor to the CEO through April 6, 2027. The CFO change is a significant leadership transition, and the filing details Latino's base salary, bonus targets and severance terms.
Michael S. Bishop ceases as CFO effective October 6, 2026; the Board deemed his separation a termination without cause
Matthew Latino, 41, previously served as Senior Vice President, Finance and Segment CFO at Xylem Inc. from November 2025 to June 2026
Latino's employment agreement provides a $460,000 base salary, a 70% target bonus for fiscal 2027 and a $1,000,000 target long-term incentive award
On October 6, 2026, SRX Global entered a Stock Purchase Agreement to acquire all outstanding stock of CERo Therapeutics, Inc., a wholly owned subsidiary of CERo Therapeutics Holdings, Inc. Consideration includes $1,000,000 in SRX common stock, discharge of a senior secured note with an outstanding principal balance of $8,249,643.77, and assumption of about $1,562,000 in liabilities. Completion depends on a 30-day go-shop period, the acquisition of Holdings' Series C, D and E preferred stock, and conditions tied to its Series A preferred stock, so shareholders face both the share issuance and the uncertainty of closing.
Consideration: $1,000,000 of SRX common stock, discharge of the Consolidated Note (outstanding principal $8,249,643.77 as of the filing date), and assumption of about $1,562,000 in liabilities
30-day go-shop period from the October 6, 2026 signing, conducted by Joseph Gunnar & Co., LLC, during which Holdings may solicit alternative proposals
Holdings must pay a $750,000 termination fee in specified cases; SRX may owe Holdings $750,000 in specified cases involving its failure to fund
Closing requires SRX to acquire Holdings' Series C, D and E preferred stock; the agreement is not subject to a financing condition
Azenta said its board approved a restructuring plan on October 5, 2026, to consolidate its North American laboratory network, cut workforce and close three Multiomics sites in North America. The company estimates $11.0 million to $13.0 million in pre-tax charges, mostly non-cash impairments, with about $7.0 million in future cash spending and about $11.0 million in annualized savings once fully implemented.
Plan approved October 5, 2026, within the Multiomics segment; employee notifications began October 6, 2026
Estimated pre-tax charges of $11.0 million to $13.0 million, including about $9.0 million of asset impairment and about $3.0 million of severance and other restructuring
Estimated future cash expenditures of about $7.0 million; expected annualized cost savings of about $11.0 million
Most charges expected in the fiscal year ending September 30, 2027; actions substantially complete by March 31, 2027
On October 5, 2026, Spyre Therapeutics agreed to sell 4,117,648 shares of common stock at $85.00 per share, with expected gross proceeds of about $350.0 million before underwriting discounts and offering expenses. The underwriters also received a 30-day option to buy up to 617,647 additional shares, and closing is expected on or about October 7, 2026. Because the offering adds new shares, existing shareholders' ownership will be diluted once it closes, and the proceeds are earmarked for pipeline programs in gastroenterology, rheumatology, dermatology, and SPY072 for hidradenitis suppurativa.
4,117,648 shares offered at $85.00 per share, with Jefferies LLC and other firms as representatives of the underwriters
Expected gross proceeds of about $350.0 million before underwriting discounts and estimated offering expenses
Underwriters hold a 30-day option to purchase up to 617,647 additional shares; closing expected on or about October 7, 2026
Proceeds to fund programs in Gastroenterology, Rheumatology and Dermatology, including late-stage development of SPY072 for hidradenitis suppurativa
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.